FDA recall, , Moderate risk
Central California Blood Center Red Blood Cells and Pathogen Reduced Cryoprecipitated Fibrinogen Complex
Pathogen Reduced Cryoprecipitated Fibrinogen Complex and Red Blood Cells were collected from a donor not re-entered after positive Chagas testing.
Recall ended Sep 28, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Central California Blood Center began a recall on June 1, 2026, of Pathogen Reduced Cryoprecipitated Fibrinogen Complex and Red Blood Cells, Leukocytes Reduced, because they were collected from a donor who was not re-entered appropriately after positive testing for Chagas. The products were distributed in California and Illinois. The FDA added the recall to its Enforcement Report on September 28, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
2 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Pathogen Reduced Cryoprecipitated Fibrinogen Complex
Reason: Pathogen Reduced Cryoprecipitated Fibrinogen Complex, collected from a donor who was not re-entered appropriately after positive testing for Chagas, were distributed.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, collected from a donor who was not re-entered appropriately after positive testing for Chagas, were distributed.
Recall details
- Company began the recall
- Sold in
- Company
- Central California Blood Center
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99555
- Recall numbers
- B-0274-2026 to B-0275-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
